Eyevance Pharmaceuticals added Julie Speed to its executive team as the chief commercial officer, onboarding a leader with more than 21 years of experience.
What you should know:
1. Ms. Speed will develop a commercial strategy for the company's Eyevance product portfolio.
2. She comes to Eyevance from Johnson & Johnson Vision where she most recently served as senior director of U.S. marketing.
3. Ms. Speed has a storied career, including tenures at TearLab Corp., and Alcon.
She commented on Eyevance's portfolio, saying, "Eyevance's robust product pipeline of commercial and development-stage assets have the opportunity to address many unmet ophthalmic market needs, which will position the organization for sustained success in 2020 and beyond."
More articles on surgery centers:
ASC supply chain tip of the day: Prepare for shortages
3 recent updates on Medline
6 ASC supply chain tips